Association between high-density lipoprotein cholesterol and breast cancer varies by menopausal status

Cancer Epidemiology Biomarkers and Prevention

Volumn 7, Issue 6, 1998, Pages 483-488

  Moorman, Patricia G ^a,e   Hulka, Barbara S ^a   Hiatt, Robert A ^b   Krieger, Nancy ^c   Newman, Beth ^a   Vogelman, Joseph H ^d   Orentreich, Norman ^d  

^a IL   (United States)

^b DIVISION OF RESEARCH   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d Orentreich Foundation for the Advancement of Science Inc   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CHOLESTEROL BLOOD LEVEL; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; ODDS RATIO; QUESTIONNAIRES; RISK; RISK FACTORS;

EID: 0031879253     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Boyd, N. F., and McGuire V. Evidence of association between plasma high-density lipoprotein cholesterol and risk factors for breast cancer J. Natl. Cancer Inst., 82: 460-468, 1990.
2. Muir, C., Waterhouse, J., Mack, T., Powell, J., and Whelan, S. (eds) Cancer Incidence in Five Continents New York. Oxford University Press, 1987.
3. Wynder, E. L. Dietary factors related to breast cancer. Cancer (Phila.), 46 899-904, 1980.
4. Kesteloot, H., Huang, D. X., Yand, X. S., Claes, J., Rosseneu, M., Geboers, J., and Joossens, J. V. Serum lipids in the People's Republic of China Arteriosclerosis, 5: 427-433, 1985.
5. Punnonen, R., Jokela, H., Kudo, R., Punnonen, K., Pyykko, K., and Pystynene, P. Serum lipids in Finnish and Japanese postmenopausal women. Atherosclerosis, 68: 241-247, 1987.
6. Halfon, S-T., Rifkind, B. M., Harlap, S., Kaufmann, N. A., Baras, M., Slater, P. E., Halperin, G., Eisenberg, S., Davies, A. M., and Stein, Y. Plasma lipids and lipoproteins in adult Jews of different origins' the Jerusalem Lipid Research Clinics Prevalence Study. Isr. J. Med. Sci., 18: 1113-1119, 1982.
7. Kelsey, J. L. (ed.). Breast cancer. Epidemiol Rev., 15: 1-263, 1993.
8. Ness, R. B., Schotland, H. M., Flegal, K. M., and Shofer, F. S. Reproductive history and coronary heart disease risk in women. Epidemiol Rev., 16: 298-314, 1994.
9. Bush, T. L., and Miller, V. T. Effects of pharmacologic agents used during menopause impact on lipids and lipoproteins. In: J. D. Ryan (ed), Menopause, Physiology and Pharmacology, pp. 187-208. Chicago: Year Book Medical Publishers, 1987.
10. Linn, S., Fulwood, R., Rifkind, B., Carroll, M., Muesing, R., Williams, O. D., and Johnson, C. High-density lipoprotein cholesterol levels among U. S. adults by selected demographic and socioeconomic variables The Second National Health and Nutrition Examination Survey 1976-1980. Am J. Epidemiol., 129, 281-294, 1989.
11. Gospodarowicz, D., Lui, G-M., and Gonzalez, R. High-density lipoproteins and the proliferation of human tumor cells maintained on extracellular matrix coated dishes and exposed to defined medium. Cancer Res., 42: 3704-3713, 1982.
12. Jozan, S., Faye, J. C., Tournier, J. F., Tauber, J. P., David, J. F., and Bayard, F. Interaction of estradiol and high density lipoproteins on proliferation of the human breast cancer cell line MCF-7 adapted to grow in serum free conditions. Biochem. Biophys Res Commun., 133: 105-112, 1985.
13. Rotheneder, M., and Kostner, G. M. Effects of low- and high-density lipoproteins on the proliferation of human breast cancer cells in vitro: differences between hormone-dependent and hormone-independent cell lines Int J. Cancer. 43: 875-879, 1989.
14. Knapp, M. L., Al-Sheibani, S., and Riches, P. G. Alterations of serum lipids in breast cancer: effects of disease activity, treatment and hormonal factors Clin Chem., 37: 2093-2101, 1991.
15. Kökoglu, E., Karaarslan, I., Karaarslan, H. M., and Baloglu, H. Alterations of serum lipids and lipoproteins in breast cancer Cancer Lett., 82: 175-178, 1994.
16. Høyer, A. P., and Engholm, G. Serum lipids and breast cancer risk: a cohort study of 5,207 Danish women. Cancer Causes Control, 3: 403-408, 1992.
17. Gaard, M., Tretli, S., and Urdal, P. Risk of breast cancer in relation to blood lipids: a prospective study of 31,209 Norwegian women Cancer Causes Control. 5: 501-509, 1994.
18. McMichael, A. J., Jensen, O. M., Parkin, D. M., and Zaridze, D. G. Dietary and endogenous cholesterol and human cancer. Epidemiol Rev. 6: 192-216, 1984.
19. Collen, M. F., and Davis, L. F. The multitest laboratory in health care. J Occup Med., 11: 355-360, 1969.
20. Friedman, G. D., Blaner, W. S., Goodman, D. S., Vogelman, J. H., Brind, J. L., Hoover, R., Fireman, B. H., and Orentreich, N. Serum retinol and retinol-binding protein levels do not predict subsequent lung cancer. Am. J. Epidemiol., 123: 781-789, 1986.
21. Bachorik, P. S. Measurement of total cholesterol, HDL-C-cholesterol, and LDL cholesterol. Clin. Lab. Med., 9: 61-72, 1989.
22. SAS Institute Inc. SAS Technical Report P-217. SAS/STAT Software. The PHREG Procedure, Version 6. Cary, NC: SAS Institute Inc., 1991.
23. Rao, C. R. Linear Statistical Interence and Its Applications, Chapter 6, Large sample theory and methods, pp. 350-351 New York: John Wiley and Sons, 1965.
24. Kleinbaum, D. G., Kupper, L. L., and Morgenstern, H. Epidemiologic Research, Chapter 21, pp 447-456, Modeling: analysis strategy, Chapter 24, pp 492-502, Applications of modeling: conditional likelihood estimation. New York: Van Nostrand Reinhold, 1982.
25. Vital and Health Statistics. Serum Lipids of Adults 20-74 Years: United States, 1976-80 [DHHS Publication No. (PHS) 93-1962]. Hyattsville, MD: U. S. Department of Health and Human Services, 1993.
26. Heiss, G., Johnston, M. J., Reiland, S., Davis, C. E., and Tyroler, H. A. The epidemiology of plasma high-density lipoprotein cholesterol levels: the Lipid Research Clinics Program Prevalence Study Circulation, 62 (Suppl. 6): 116-136, 1980.
27. Bush, T. L., Barrett-Connor, E., Cowan, L. D., Criqui, M. H., Wallace, R. B., Suchindran, C. M., Tyroler, H. A., and Rifkind, B. M. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study Circulation, 75: 1102-1109, 1987.
28. Friedenreich, C. M., and Rohan, T. E. A review of physical activity and breast cancer. Epidemiology, 6: 311-317, 1995.